Equity (Tables)

6 Months Ended

Mar. 31, 2016

Equity [Abstract]

Schedule of Stock Options Activity

The following table summarizes stock option activity under the Equity Plans for the six months ended March 31, 2016:

	Number of Shares		Weighted Average Exercise Price	Weighted Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2015	696,459		$22.47
Granted	16,700		$6.37
Exercised	(37,413	)	$4.98		$	80
Forfeited	(5,700	)	$6.35
Expired	(52,099	)	$31.22
Outstanding as of March 31, 2016	617,947		$22.51	2.76	$	97
Exercisable as of March 31, 2016	567,172		$23.97	2.18	$	97
Vested and expected to vest as of March 31, 2016	607,534		$22.79	2.65	$	97

(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the six months ended March 31, 2015, the intrinsic value of options exercised was $95,000.

Schedule of Valuation Assumptions

The fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option valuation model, adhering to the straight-line attribution approach using the following weighted-average assumptions, of which the expected term and stock price volatility rate are highly subjective:

	For the three months ended March 31,					For the six months ended March 31,
	2016		2015			2016			2015
Black-Scholes weighted average assumptions:
Expected dividend rate	—	%	—		%	—		%	—		%
Expected stock price volatility rate	61.0	%	72.7		%	61.3		%	76.0		%
Risk-free interest rate	1.5	%	1.7		%	1.6		%	1.8		%
Expected term (in years)	6.0		6.0			6.0			6.0
Weighted average grant date fair value per share of stock options granted:	$2.97		$	3.51		$	3.64		$	3.55

Schedule of Restricted Stock Activity

The following table summarizes the activity related to RSUs for the six months ended March 31, 2016:

Restricted Stock Activity	Restricted Stock Units
	Number of Shares		Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2015	570,231		$5.26
Granted	280,650		$5.22
Vested	(251,970	)	$5.14
Forfeited	(7,916	)	$5.15
Non-vested as of March 31, 2016	590,995		$5.30

Schedule of Stock-based Compensation Expense - By Award Type

The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type	For the three months ended March 31,				For the six months ended March 31,
(in thousands)	2016		2015		2016		2015
Employee stock options	$	10	$	7	$	16	$	184
Restricted stock awards and units	453		797		719		2,056
Employee stock purchase plan	56		14		111		64
401(k) match in common stock	—		144		—		224
Outside director fees in common stock	94		72		130		280
Total stock-based compensation expense	$	613	$	1,034	$	976	$	2,808

Schedule Stock-based Compensation Expense - By Expense Type

Stock-based Compensation Expense - by expense type	For the three months ended March 31,				For the six months ended March 31,
(in thousands)	2016		2015		2016		2015
Cost of revenue	$	113	$	81	$	182	$	185
Selling, general, and administrative	420		849		608		2,414
Research and development	80		104		186		209
Total stock-based compensation expense	$	613	$	1,034	$	976	$	2,808

Schedule of Earnings Per Share, Basic and Diluted

Income (Loss) Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share:

Basic and Diluted Net Income (loss) Per Share	For the three months ended March 31,						For the six months ended March 31,
(in thousands, except per share)	2016			2015			2016			2015
Numerator:
Loss from continuing operations	$	(162	)	$	(956	)	$	(296	)	$	(4,086	)
Income from discontinued operations	4,144			4,008			5,265			63,266
Undistributed earnings allocated to common shareholders for basic and diluted net (loss) income per share	3,982			3,052			4,969			59,180
Denominator:
Denominator for basic and diluted net income (loss) per share - weighted average shares outstanding	25,942			32,077			25,818			31,640
Net income (loss) per basic and diluted share:
Continuing operations	$	(0.01	)	$	(0.03	)	$	(0.01	)	$	(0.13	)
Discontinued operations	0.16			0.13			0.20			2.00
Net income per basic and diluted share	$	0.15		$	0.10		$	0.19		$	1.87
Weighted average antidilutive options, unvested restricted stock units and awards, warrants and ESPP shares excluded from the computation	721			2,214			794			2,434
Average market price of common stock	$	5.44		$	5.34		$	6.19		$	5.32

Schedule of Common Stock Reserved for Future Issuances

As of March 31, 2016, we had common stock reserved for the following future issuances:

Future Issuances	Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options	617,947
Unvested restricted stock units	590,995
Purchases under the employee stock purchase plan	881,706
Issuance of stock-based awards under the Equity Plans	837,887
Purchases under the officer and director share purchase plan	88,741
Issuance of deferred stock-based awards under the Directors' Stock Award Plan, as amended	22,163
Total reserved	3,039,439